ALPS
2016
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
In 3,026 adults with OHCA and shock-refractory VF/pVT, amiodarone or lidocaine did not improve survival to hospital discharge versus placebo.
Result
Primary endpoint: Survival to hospital discharge
24.4% (amiodarone) vs 23.7% (lidocaine) vs 21.0% (placebo); benefit in witnessed bystander-arrest subgroup.
- Subtopic
- Antiarrhythmics
- Design
- Double-blind RCT, North America
- Relevance
- Supporting: context rather than must-know.
- Source
- Kudenchuk PJ, et al. N Engl J Med. 2016;374(18):1711-1722.doi 10.1056/NEJMoa1514204
Discussion & critique
Antiarrhythmics remain a weak recommendation; bystander CPR and early defibrillation are the real life-savers.